Skip Navigation

Cardiovascular Research 2007 73(3):488-496; doi:10.1016/j.cardiores.2006.11.003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Pierre, S. V.
Right arrow Articles by Xie, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pierre, S. V.
Right arrow Articles by Xie, Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2006, European Society of Cardiology

Ouabain triggers preconditioning through activation of the Na+,K+-ATPase signaling cascade in rat hearts

Sandrine V. Pierrea, Changjun Yanga, Zhaokan Yuana, Jennifer Seminerioa, Christian Mouasb, Keith D. Garlidc, Pierre Dos-Santosd and Zijian Xiea,*

aDepartment of Physiology, Pharmacology, Metabolism and Cardiovascular Sciences, Medical University of Ohio, 3035 Arlington Avenue, Toledo, OH 43614-5804, United States
bInserm U689, Centre de Cardiologie vasculaire de Lariboisiere, Paris, France
cDepartment of Biology, Portland State University, Portland, Oregon, United States
dInserm U.441, Avenue du Haut Leveque, Pessac, France

* Corresponding author. Tel.: +1 419 383 4182; fax: +1 419 383 2871. Email address: zxie{at}meduohio.edu

Objective: Because ouabain activates several pathways that are critical to cardioprotective mechanisms such as ischemic preconditioning, we tested if this digitalis compound could protect the heart against ischemia–reperfusion injury through activation of the Na+,K+-ATPase/c-Src receptor complex.

Methods and results: In Langendorff-perfused rat hearts, a short (4 min) administration of ouabain 10 µM followed by an 8-minute washout before 30 min of global ischemia and reperfusion improved cardiac function, decreased lactate dehydrogenase release and reduced infarct size by 40%. Western blot analysis revealed that ouabain activated the cardioprotective phospholipase C{gamma}1/protein kinase C{varepsilon} (PLC-{gamma}1/PKC{varepsilon}) pathway. Pre-treatment of the hearts with the Src kinase family inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolol[3,4-d]pyrimidine (PP2) blocked not only ouabain-induced activation of PLC-{gamma}1/PKC{varepsilon} pathway, but also cardiac protection. This protection was also blocked by a PKC{varepsilon} translocation inhibitor peptide (PKC{varepsilon} TIP).

Conclusion: Short exposure to a low concentration of ouabain protects the heart against ischemia/reperfusion injury. This effect of ouabain on the heart is most likely due to the activation of the Na+,K+-ATPase/c-Src receptor complex and subsequent stimulation of key mediators of preconditioning, namely PLC-{gamma}1 and PKC{varepsilon}.

KEYWORDS Ischemia; Reperfusion; Signal transduction; Na/K-pump

Time for primary review 15 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.